• Home
  • Submit news
  • Advertise with us
  • Home
  • Submit news
  • Advertise with us
Converter News
  • Converting
  • Print News
  • Food
  • Packaging
  • Manufacturing
  • Paper
  • Plastic
  • Nonwovens
Menu
  • Converting
  • Print News
  • Food
  • Packaging
  • Manufacturing
  • Paper
  • Plastic
  • Nonwovens
loading...
BREAKING NEWS
  • Manhattan Associates partners with robotics companies, automation provider and consultant
  • DOE recognizes Better Buildings Initiative partners
  • Zebra Technologies to acquire Profitect Inc.
  • Merck acquires Peloton Therapeutics for $1 billion
  • Making the Case for Lift Truck/MRO, Maintain and sustain your operations
  • IBM delivers basics of blockchain for logistics
  • Essity Divests Stake in Turkish Buisness
  • Mallinckrodt sues US health agencies after Medicaid changes
  • I.D. Images appoints two new account executives
  • Weldon Celloplast to distribute TrojanLabel equipment in India
Home FDA approves Progenics’ drug for rare tumors

FDA approves Progenics’ drug for rare tumors

on: July 31, 2018In:
Print Email
The drug, Azedra, was approved to treat patients above the age of 12 who have either of the two tumors, pheochromocytoma or paraganglioma, and require anti-cancer therapy

Source: Pharma Manufacturing
More...

Share 0
Tweet
Share
Share
Share
  • FDA approves Progenics' drug for rare tumors
    Previous

    Willow Launches Disposable Incontinence Underwear

  • FDA approves Progenics' drug for rare tumors
    Next

    Domino to Bring ‘Digital Printing Spectrum’ Event to Label Expo

Facebook